HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.

AbstractAIM:
To verify possible associations among glucocorticoid doses, use of dexamethasone, and bone mineral density (BMD), measured by dual X-ray absorptiometry (DXA) and quantitative computed tomography (QCT), in female children with congenital adrenal hyperplasia due to CYP21 deficiency (CAH-CYP21). Classical CAH-CYP21 in females allows the study of the effects of hyperandrogenism and chronic glucocorticoid exposure.
DESIGN:
Cross-sectional observational study.
PATIENTS:
Sixteen girls (4-19 years) with CAH-CYP21 and 32 age-matched control girls.
MEASUREMENTS:
BMD was the main outcome measure assessed by total body and lumbar spine L1-L4 DXA (DXAtot and DXAIs), lumbar spine L1-L4 bone mineral apparent density (BMAD) and spinal L1-L4 QCT of trabecular (QCTtrab) and cortical (QCTcort) bone. The glucocorticoid dose used by patients with CAH-CYP21 was expressed as hydrocortisone equivalents/m2.
RESULTS:
Mean BMD in both groups was similar by any method. In patients, BMD decreased with the increasing mean dose of glucocorticoid, seen in QCTcort (r = -0.55; p = 0.03) and QCTtrab (r = -0.52; p = 0.04). There was also a negative correlation between cumulative glucocorticoid dose and BMD in QCTcort (beta = -0.0016; p = 0.005) and QCTtrab (beta = -0.0009; p = 0.03).
CONCLUSIONS:
The dose of glucocorticoid used in the treatment of girls with CAH-CYP21 correlated negatively with BMD, and dexamethasone was not selectively harmful.
AuthorsRegina Helena Elnecave, Cristiane Kopacek, Marilia Rigatto, Juliana Keller Brenner, José Augusto Sisson de Castro
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 21 Issue 12 Pg. 1155-62 (Dec 2008) ISSN: 0334-018X [Print] Germany
PMID19189689 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • Dexamethasone
  • CYP21A2 protein, human
  • Steroid 21-Hydroxylase
Topics
  • Absorptiometry, Photon
  • Adolescent
  • Adrenal Hyperplasia, Congenital (drug therapy, genetics, physiopathology)
  • Body Mass Index
  • Bone Density (drug effects, physiology)
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Dexamethasone (pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Glucocorticoids (pharmacology, therapeutic use)
  • Humans
  • Hyperandrogenism (physiopathology)
  • Lumbar Vertebrae (diagnostic imaging, physiopathology)
  • Steroid 21-Hydroxylase (genetics)
  • Tomography, X-Ray Computed
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: